Hemophagocytosis in Critically Ill Adult Patients
Recruiting
Observational Study
Hemophagocytosis
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 – 90
- Sex
- Any
- Study type
- Observational
- Participants needed
- 40 (estimated)
- Sponsor
- University of Ulm · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The purpose of the study is to find out whether non-responsiveness to therapeutic recombinant human granulocyte colony-stimulation factor (rhG-CSF) is associated with hemophagocytosis in critically ill adult patients with cytopenias.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* age \> 18 years
* critically ill adult patients
* leukopenia and thrombocytopenia
* rhG-CSF therapy
Exclusion Criteria:
* life expectancy \< 24 hours
* inclusion in other studies
* trauma patients with reanimation on scene or immediately dying on hospital admission
* pregnan…
Contacts